雀巢“渡劫”？惠氏中国员工批量“毕业”震荡未平，婴配粉又陷全球召回危机

Core Viewpoint - Nestlé is currently facing a dual crisis involving a global recall of infant formula products due to quality issues with raw materials and internal restructuring challenges following the merger of its Wyeth and infant nutrition businesses in China [1][10][16]. Internal Challenges - The merger of Wyeth and Nestlé's infant nutrition business in China has led to significant personnel optimization, with reports of a 30%-50% reduction in frontline staff across various provinces [3][4]. - Employees who remain are experiencing management voids and unclear operational processes, leading to difficulties in executing their roles effectively [4][6]. - The restructuring has resulted in a lack of support for sales activities, with many products experiencing price increases and reduced promotional activities, further complicating sales efforts for remaining staff [6][12]. External Crisis - Nestlé has initiated a global recall of multiple batches of infant formula due to potential contamination with a toxin from a supplier's raw material, which poses health risks to infants [10][12]. - The recall has expanded to include products sold through cross-border e-commerce channels in China, with significant consumer concern leading to the formation of advocacy groups for product returns [10][11]. - Despite the recall being labeled as a preventive measure, the potential impact on brand trust, especially in the sensitive infant nutrition market, is significant [12][16]. Market Context - The merger and subsequent challenges come at a time when Nestlé's performance in the Greater China region has been under pressure, with an organic growth rate of -6.1% reported for the first three quarters of 2025 [16]. - The global strategy includes a plan to lay off approximately 16,000 employees, representing 6% of the workforce, aimed at optimizing cost structures and accelerating transformation [16].